Fulphila

Fulphila is a biosimilar medication containing pegfilgrastim, used to stimulate white blood cell production. It is commonly administered via subcutaneous injection and is manufactured by Biosimilar Collaborations Ireland Limited.

Fulphila is primarily used to help the body produce more white blood cells, which are crucial for fighting infections. This medication is often prescribed to individuals undergoing certain types of chemotherapy to support their immune system. People often search for 'what is Fulphila used for' when looking for information on its therapeutic applications.

Fulphila works by stimulating the bone marrow to produce more white blood cells. Common effects may include mild injection site reactions, such as redness or swelling. Some individuals might experience bone or muscle aches as their body responds to the medication.

Fulphila should be handled with care and stored as directed. It is important to follow the healthcare provider's instructions for administration. Individuals with known allergies to pegfilgrastim or any of its components should avoid using this medication.

Fulphila may interact with other medications, so it is important to inform your healthcare provider about all the drugs you are taking. Alcohol and certain supplements might also affect how Fulphila works in the body.